Advertisement
ARRY vs SPRU
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARRY is a Buy and SPRU is a Buy.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ARRY’s TA Score shows that 5 TA indicator(s) are bullish while SPRU’s TA Score has 6 bullish TA indicator(s).
- ARRY’s TA Score: 5 bullish, 5 bearish.
- SPRU’s TA Score: 6 bullish, 3 bearish.
| ARRY | SPRU | ARRY / SPRU | |
| Capitalization | 2.22B | 72.6M | 3,061% |
| EBITDA | 276M | -15.02M | -1,838% |
| Gain YTD | 3.311 | -33.333 | -10% |
| P/E Ratio | 26.23 | N/A | - |
| Revenue | 1.58B | 82.3M | 1,916% |
| Total Cash | 249M | 154M | 162% |
| Total Debt | 730M | 634M | 115% |
ARRY | SPRU | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 53 | 13 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 99 Overvalued | 66 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 100 | 97 | |
PRICE GROWTH RATING 1..100 | 58 | 64 | |
P/E GROWTH RATING 1..100 | 26 | 97 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
SPRU's Valuation (66) in the Multi Line Insurance industry is somewhat better than the same rating for ARRY (99) in the Biotechnology industry. This means that SPRU’s stock grew somewhat faster than ARRY’s over the last 12 months.
SPRU's Profit vs Risk Rating (100) in the Multi Line Insurance industry is in the same range as ARRY (100) in the Biotechnology industry. This means that SPRU’s stock grew similarly to ARRY’s over the last 12 months.
SPRU's SMR Rating (97) in the Multi Line Insurance industry is in the same range as ARRY (100) in the Biotechnology industry. This means that SPRU’s stock grew similarly to ARRY’s over the last 12 months.
ARRY's Price Growth Rating (58) in the Biotechnology industry is in the same range as SPRU (64) in the Multi Line Insurance industry. This means that ARRY’s stock grew similarly to SPRU’s over the last 12 months.
ARRY's P/E Growth Rating (26) in the Biotechnology industry is significantly better than the same rating for SPRU (97) in the Multi Line Insurance industry. This means that ARRY’s stock grew significantly faster than SPRU’s over the last 12 months.
| ARRY | SPRU | |
|---|---|---|
| RSI ODDS (%) | 7 days ago 88% | N/A |
| Stochastic ODDS (%) | 2 days ago 88% | 2 days ago 84% |
| Momentum ODDS (%) | 2 days ago 88% | 2 days ago 75% |
| MACD ODDS (%) | 2 days ago 90% | 2 days ago 80% |
| TrendWeek ODDS (%) | 2 days ago 89% | 2 days ago 77% |
| TrendMonth ODDS (%) | 2 days ago 84% | 2 days ago 70% |
| Advances ODDS (%) | 16 days ago 80% | 7 days ago 78% |
| Declines ODDS (%) | 2 days ago 90% | 14 days ago 88% |
| BollingerBands ODDS (%) | 2 days ago 90% | 2 days ago 89% |
| Aroon ODDS (%) | 2 days ago 70% | 2 days ago 87% |
Advertisement